دورية أكاديمية
In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K
العنوان: | In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K |
---|---|
المؤلفون: | Vinothini Boopathi, Jinnatun Nahar, Mohanapriya Murugesan, Sathiyamoorthy Subramaniyam, Byoung Man Kong, Sung-Keun Choi, Chang-Soon Lee, Li Ling, Dong Uk Yang, Deok Chun Yang, Ramya Mathiyalagan, Se Chan Kang |
المصدر: | Heliyon, Vol 9, Iss 9, Pp e19341- (2023) |
بيانات النشر: | Elsevier, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Science (General) LCC:Social sciences (General) |
مصطلحات موضوعية: | Ginsenoside, Compound K, ACE-2, TMPRSS2, Molecular docking, Molecular dynamics simulation, Science (General), Q1-390, Social sciences (General), H1-99 |
الوصف: | SARS-CoV-2 is a novel coronavirus that emerged as an epidemic, causing a respiratory disease with multiple severe symptoms and deadly consequences. ACE-2 and TMPRSS2 play crucial and synergistic roles in the membrane fusion and viral entry of SARS-CoV-2 (COVID-19). The spike (S) protein of SARS-CoV-2 binds to the ACE-2 receptor for viral entry, while TMPRSS2 proteolytically cleaves the S protein into S1 and S2 subunits, promoting membrane fusion. Therefore, ACE-2 and TMPRSS2 are potential drug targets for treating COVID-19, and their inhibition is a promising strategy for treatment and prevention. This study proposes that ginsenoside compound K (G-CK), a triterpenoid saponin abundant in Panax Ginseng, a dietary and medicinal herb highly consumed in Korea and China, effectively binds to and inhibits ACE-2 and TMPRSS2 expression. We initially conducted an in-silico evaluation where G-CK showed a high affinity for the binding sites of the two target proteins of SARS-CoV-2. Additionally, we evaluated the stability of G-CK using molecular dynamics (MD) simulations for 100 ns, followed by MM-PBSA calculations. The MD simulations and free energy calculations revealed that G-CK has stable and favorable energies, leading to strong binding with the targets. Furthermore, G-CK suppressed ACE2 and TMPRSS2 mRNA expression in A549, Caco-2, and MCF7 cells at a concentration of 12.5 μg/mL and in LPS-induced RAW 264.7 cells at a concentration of 6.5 μg/mL, without significant cytotoxicity.ACE2 and TMPRSS2 expression were significantly lower in A549 and RAW 264.7 cells following G-CK treatment. These findings suggest that G-CK may evolve as a promising therapeutic against COVID-19. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2405-8440 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2405844023065490; https://doaj.org/toc/2405-8440 |
DOI: | 10.1016/j.heliyon.2023.e19341 |
URL الوصول: | https://doaj.org/article/c049dc7b962c4237bb28be25b27d1890 |
رقم الأكسشن: | edsdoj.049dc7b962c4237bb28be25b27d1890 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 24058440 |
---|---|
DOI: | 10.1016/j.heliyon.2023.e19341 |